Cargando…
IL-12/IL-23p40 identified as a downstream target of apremilast in ex vivo models of arthritis
BACKGROUND: Apremilast (Otezla(®)) is a phosphodiesterase 4 (PDE4) inhibitor approved for the treatment of psoriasis and psoriatic arthritis (PsA), but the reason why apremilast shows clinical effect is not fully understood. The objective of this study was to study the downstream effects of apremila...
Autores principales: | Kragstrup, Tue W., Adams, Mary, Lomholt, Søren, Nielsen, Morten A., Heftdal, Line D., Schafer, Peter, Deleuran, Bent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391542/ https://www.ncbi.nlm.nih.gov/pubmed/30833991 http://dx.doi.org/10.1177/1759720X19828669 |
Ejemplares similares
-
The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis
por: Kragstrup, Tue W., et al.
Publicado: (2018) -
Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritis
por: Køster, Ditte, et al.
Publicado: (2021) -
Responses to Cytokine Inhibitors Associated with Cellular Composition in Models of Immune‐Mediated Inflammatory Arthritis
por: Nielsen, Morten A., et al.
Publicado: (2019) -
A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients
por: Kragstrup, Tue W, et al.
Publicado: (2013) -
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts
por: Nielsen, Morten A., et al.
Publicado: (2023)